Xie Y - Search Results

1

Advanced diffuse hepatic angiosarcoma treated successfully with TACE and targeted immunotherapy: A case report.

Lin Y, Chen Z, Yang J, Lin Y, Chen S, Xie Y, Wu S. Lin Y, et al. Among authors: xie y. Front Oncol. 2023 Apr 20;13:1071403. doi: 10.3389/fonc.2023.1071403. eCollection 2023. Front Oncol. 2023. PMID: 37152029 Free PMC article.

2

Percutaneous ultrasound-guided core needle biopsy for the diagnosis of cardiac tumors: Optimizing the treatment strategy for patients with intermural and pericardial cardiac tumors.

Xie Y, Hong ZL, Zhao YC, Chen S, Lin YC, Wu SS. Xie Y, et al. Front Oncol. 2022 Aug 5;12:931081. doi: 10.3389/fonc.2022.931081. eCollection 2022. Front Oncol. 2022. PMID: 35992842 Free PMC article.

3

Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China.

Zha J, Fan L, Yi S, Yu H, Zheng Z, Xu W, Deng M, Lin Z, Li Z, Ping L, He X, Chen F, Xie Y, Chen B, Zhang H, Wang L, Ding K, Li W, Yang H, Zhao W, Qiu L, Li Z, Song Y, Xu B. Zha J, et al. Among authors: xie y. J Hematol Oncol. 2021 Aug 23;14(1):131. doi: 10.1186/s13045-021-01139-6. J Hematol Oncol. 2021. PMID: 34425858 Free PMC article.

4

Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3⁺ T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome Patients.

Huang Y, Hong M, Qu Z, Zheng W, Hu H, Li L, Lu T, Xie Y, Ying S, Zhu Y, Liu L, Huang W, Fu S, Chen J, Wu K, Liu M, Luo Q, Wu Y, He F, Zhang J, Zhang J, Chen Y, Zhao M, Cai Z, Huang H, Sun J. Huang Y, et al. Among authors: xie y. Front Oncol. 2021 Oct 13;11:741341. doi: 10.3389/fonc.2021.741341. eCollection 2021. Front Oncol. 2021. PMID: 34722293 Free PMC article.

5

[Rituximab-Based Regimens for Treatment of Primary Gastric Diffuse Large B-Cell Lymphoma].

Qu S, Liao LS, Zheng ZH, Xie Y, Chen WM, Chen BY. Qu S, et al. Among authors: xie y. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Jun;30(3):760-764. doi: 10.19746/j.cnki.issn.1009-2137.2022.03.016. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 35680802 Chinese.

6

[Intracranial involvement in newly diagnosed multiple myeloma with TP53 deletion: Two case reports].

Qu S, Liao L, Xie Y, Zheng Z, Chen B. Qu S, et al. Among authors: xie y. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Nov 28;43(11):1272-1275. doi: 10.11817/j.issn.1672-7347.2018.11.018. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018. PMID: 30643076 Free article. Chinese.

7

[Evaluation of the Short-Term Efficacy and Safety of Orelabrutinib Combined with High-Dose Methotrexate in the First-line Treatment of Elderly Patients with High Risk Primary Central Nervous System Lymphoma].

Xie Y, Qu S, Liao LS, Zheng ZH, Lin Y, Chen WM, Chen BY. Xie Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Dec;31(6):1714-1719. doi: 10.19746/j.cnki.issn.1009-2137.2023.06.017. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 38071050 Chinese.

8

Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China.

Lin Z, Zha J, Yi S, Li Z, Ping L, He X, Fan L, Yu H, Zheng Z, Xu W, Chen F, Xie Y, Chen B, Zhang H, Wang L, Ding K, Li W, Yang H, Zhao W, Qiu L, Li Z, Song Y, Xu B. Lin Z, et al. Among authors: xie y. Clin Transl Oncol. 2023 Jun;25(6):1821-1829. doi: 10.1007/s12094-023-03081-0. Epub 2023 Feb 19. Clin Transl Oncol. 2023. PMID: 36808598

9

[DA-EPOCH Chemotherapy Combined with G-CSF Effectively Mobilizes Autologous PBHSC in NHL Patients].

Liao LS, Wei TN, Zheng ZH, Qu S, Xie Y, Wang ZH, Chen BY. Liao LS, et al. Among authors: xie y. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Dec;25(6):1670-1674. doi: 10.7534/j.issn.1009-2137.2017.06.016. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 29262895 Chinese.

10

Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study.

Zha J, Chen Q, Ye J, Yu H, Yi S, Zheng Z, Xu W, Li Z, Ping L, He X, Zhang L, Li C, Xie Y, Chen F, Sun X, Su L, Zhang H, Fan L, Lin Z, Yang H, Zhao W, Qiu L, Li Z, Song Y, Xu B. Zha J, et al. Among authors: xie y. Biomark Res. 2023 Feb 6;11(1):16. doi: 10.1186/s40364-023-00462-z. Biomark Res. 2023. PMID: 36747226 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,232 results

Search Page